Accessibility links
CRISPR For Sickle Cell Disease Shows Promise In Early Test : Short Wave Earlier this month NPR health correspondent Rob Stein introduced us to Victoria Gray, the woman at the center of a groundbreaking medical treatment using CRISPR, the gene-editing technique. This week, Rob reports exclusively for NPR on the first results of that closely-watched experiment. Follow host Maddie Sofia on Twitter @maddie_sofia. Email the show at shortwave@npr.org.

Short Wave

That Revolutionary Gene-Editing Experiment? So Far So Good.

That Revolutionary Gene-Editing Experiment? So Far So Good.

Listen · 12:40
  • Download
  • <iframe src="https://www.npr.org/player/embed/780740590/780978325" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Enlarge this image

As part of a clinical trial to treat sickle cell disease, Victoria Gray (center) has vials of blood drawn by nurses Bonnie Carroll (left) and Kayla Jordan at TriStar Centennial Medical Center in Nashville, Tenn. Meredith Rizzo/NPR hide caption

toggle caption
Meredith Rizzo/NPR

As part of a clinical trial to treat sickle cell disease, Victoria Gray (center) has vials of blood drawn by nurses Bonnie Carroll (left) and Kayla Jordan at TriStar Centennial Medical Center in Nashville, Tenn.

Meredith Rizzo/NPR

Earlier this month NPR health correspondent Rob Stein introduced us to Victoria Gray, the woman at the center of a groundbreaking medical treatment using CRISPR, the gene-editing technique. This week, Rob reports exclusively for NPR on the first results of that closely-watched experiment.

Rob's original story on Victoria's results is here.

Follow host Maddie Sofia on Twitter @maddie_sofia. Email the show at shortwave@npr.org.

This episode was produced by Brent Baughman and edited by Viet Le.